1. L4 Synthetic agonistic receptor-activating BiTEs – a modular platform for the efficient targeting of acute myeloid leukemia. (1st October 2020) Authors: Benmebarek, M; Cadilha, BL; Hermann, M; Lesch, S; Augsburger, C; Brauchle, B; Stoiber, S; Darwich, A; Rataj, F; Klein, C; Hopfner, K; Subklewe, M; Endres, S; Kobold, S Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 2 Page Start: A2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P09.01 Single-cell transcriptomic atlas-guided development of chimeric antigen-receptor (CAR) T cells for the treatment of acute myeloid leukemia. (21st September 2022) Authors: Gottschlich, A; Thomas, M; Grünmeier, R; Lesch, S; Rohrbacher, L; Igl, V; Briukhovetska, D; Benmebarek, M; Dede, S; Müller, K; Xu, T; Dhoqina, D; Umut, Ö; Märkl, F; Robinson, S; Sendelhofert, A; Schulz, H; Vick, B; Cadilha, BL; Brabenec, R Journal: Journal for immunotherapy of cancer Issue: Volume 10(2022)Supplement 1 Page Start: A31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗